CRBN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.43739999797421E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.99030000036515E-07 |
Normal-vs-Stage2 |
5.403500E-04 |
Normal-vs-Stage3 |
5.80369999999553E-05 |
Normal-vs-Stage4 |
1.62707999999956E-05 |
Stage1-vs-Stage2 |
5.938400E-01 |
Stage1-vs-Stage3 |
5.628800E-01 |
Stage1-vs-Stage4 |
2.645200E-01 |
Stage2-vs-Stage3 |
4.291800E-01 |
Stage2-vs-Stage4 |
1.701170E-01 |
Stage3-vs-Stage4 |
5.581200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.16850000009272E-07 |
Normal-vs-AfricanAmerican |
4.12730000000083E-05 |
Normal-vs-Asian |
1.327390E-01 |
Caucasian-vs-AfricanAmerican |
2.275800E-01 |
Caucasian-vs-Asian |
9.127600E-01 |
AfricanAmerican-vs-Asian |
6.276600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.51700000339261E-08 |
Normal-vs-Female |
1.602880E-04 |
Male-vs-Female |
2.234400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.07159999995776E-06 |
Normal-vs-Extreme_Weight |
1.46760004149371E-09 |
Normal-vs-Obese |
3.07040000002701E-06 |
Normal-vs-Extreme_Obese |
8.353700E-02 |
Normal_Weight-vs-Extreme_Weight |
5.881600E-01 |
Normal_Weight-vs-Obese |
5.719400E-01 |
Normal_Weight-vs-Extreme_Obese |
4.249000E-01 |
Extreme_Weight-vs-Obese |
1.808170E-01 |
Extreme_Weight-vs-Extreme_Obese |
1.952050E-01 |
Obese-vs-Extreme_Obese |
5.753600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.49019999999978E-05 |
Normal-vs-Age(41-60Yrs) |
1.03100000004019E-06 |
Normal-vs-Age(61-80Yrs) |
9.15809994506134E-09 |
Normal-vs-Age(81-100Yrs) |
2.04919999999831E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.432800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.844400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.182000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.462000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.271200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.412000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
9.11079999998954E-07 |
Normal-VS-Type2 PRCC |
9.07709996056383E-09 |
Normal-VS-KIRP CIMP |
4.18410000000424E-05 |
Normal-VS-Unclassified PRCC |
8.208400E-04 |
Type1 PRCC-VS-Type2 PRCC |
3.400200E-02 |
Type1 PRCC-VS-KIRP CIMP |
2.158400E-01 |
Type1 PRCC-VS-Unclassified PRCC |
8.561600E-01 |
Type2 PRCC-VS-KIRP CIMP |
8.374400E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.871000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
4.430200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.83830000005858E-08 |
Normal-vs-N1 |
2.84580000009527E-07 |
Normal-vs-N2 |
1.49579999997318E-06 |
N0-vs-N1 |
7.340000E-01 |
N0-vs-N2 |
7.548400E-02 |
N1-vs-N2 |
1.447630E-02 |
|
|